Get the Stockscreener App
5.66
17.92%
0.86
After Hours:
5.71
0.05
+0.88%
908 Devices Inc stock is traded at $5.66, with a volume of 1.34M.
It is up +17.92% in the last 24 hours and up +24.94% over the past month.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.
See More
Previous Close:
$4.80
Open:
$4.9
24h Volume:
1.34M
Relative Volume:
1.34
Market Cap:
$157.22M
Revenue:
$59.63M
Net Income/Loss:
$-72.21M
P/E Ratio:
-2.6952
EPS:
-2.1
Net Cash Flow:
$-30.85M
1W Performance:
+27.19%
1M Performance:
+24.94%
6M Performance:
+65.01%
1Y Performance:
+1.25%
1-Day Range:
$4.85
$5.94
1-Week Range:
$4.35
$5.94
52-Week Range:
$1.81
$7.4802
908 Devices Inc Stock (MASS) Company Profile
Name
908 Devices Inc
Sector
Industry
Phone
978-729-4478
Address
645 SUMMER STREET, BOSTON
Compare MASS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASS
908 Devices Inc
|
5.66 | 157.22M | 59.63M | -72.21M | -30.85M | -2.10 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
908 Devices Inc Stock (MASS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-13-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-07-23 | Initiated | Stephens | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jan-12-21 | Initiated | Cowen | Outperform |
| Jan-12-21 | Initiated | SVB Leerink | Outperform |
| Jan-12-21 | Initiated | Stifel | Buy |
| Jan-12-21 | Initiated | William Blair | Outperform |
View All
908 Devices Inc Stock (MASS) Latest News
Lobbying Update: $22,500 of 908 DEVICES INC. lobbying was just disclosed - Nasdaq
CRISPR Therapeutics AG (CRSP) Is A Buy According To Analysts - Marketing Sentinel
MASS’s price-to-cash ratio: Is it a good investment at the moment? - uspostnews.com
908 Devices Gets $2 Million Order From Texas for Drug Detection Tools - marketscreener.com
908 Devices rises after $2 million order from Texas Department of Public Safety - TradingView
908 Devices (MASS) Secures $2M Order from Texas Department of Public Safety | MASS Stock News - GuruFocus
908 Devices Receives $2M Order From The Texas Department Of Public Safety For Drug Detection And Mitigation - marketscreener.com
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation | MASS Stock News - GuruFocus
908 Devices Receives $2M Order from the Texas Department of Public Safety for Drug Detection and Mitigation - Business Wire
Stifel maintains Buy on 908 Devices, price target steady at $6 - Investing.com Canada
908 Devices reports 55% revenue jump in Q1 By Investing.com - Investing.com South Africa
908 Devices Announces Preliminary First Quarter 2025 Financial Results - BioSpace
908 Devices expects Q1 revenue below estimates - MSN
908 Devices reports preliminary Q1 revenue $11.5M. consensus $11.9M - TipRanks
908 Devices Announces Preliminary First Quarter 2025 Financial R - GuruFocus
908 Devices Announces Preliminary Q1 2025 Financial Results - marketscreener.com
908 Devices reports 55% revenue jump in Q1 - Investing.com
908 Devices Surges with 55% Growth: Q1 Revenue Hits $11.5M After Strategic Portfolio Shift - Stock Titan
Prudential Financial Inc. Makes New Investment in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices Leads These 3 Penny Stocks To Consider - Yahoo Finance
908 Devices (NASDAQ:MASS) Earns Sell (D-) Rating from Weiss Ratings - Defense World
The Zacks Analyst Blog Highlights Fidelity NASDAQ Composite Index ETF, ThredUp, 908 Devices, Logility Supply Chain, Palomar and EZCORP - Nasdaq
Charles Schwab Investment Management Inc. Has $444,000 Stake in 908 Devices Inc. (NASDAQ:MASS) - Defense World
908 Devices (NASDAQ:MASS) Given Sell (E+) Rating at Weiss Ratings - Defense World
Q1 Earnings Estimate for 908 Devices Issued By William Blair - Defense World
Best Momentum Stocks to Buy for March 13th - Yahoo Finance
908 Devices (MASS) Stock Jumps on Strength of New Order Announcement - Stocks Telegraph
908 Devices gets $1.7M order from Ministry of Health of Ukraine - MSN
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device - 01net
908 Devices climbs on $1.7 mln order from Ukraine - TradingView
908 Devices secures $1.7 million order from Ukraine - Investing.com India
908 Devices secures $1.7 million order from Ukraine By Investing.com - Investing.com South Africa
908 Devices Receives $1.7M Order From The Ministry Of Health Of Ukraine For Its Handheld Mass Spec Device - Marketscreener.com
What Is The Outlook For 908 Devices Inc (NASDAQ: MASS) Like For Short-Term? - Stocks Register
908 Devices: Strategic Divestiture and Strong Financial Performance Drive Buy Rating - TipRanks
Repligen Corporation’s Acquisition of Bioprocessing PAT Device Portfolio from 908 Devices - Global Legal Chronicle
Weiss Ratings Reaffirms Sell (E+) Rating for 908 Devices (NASDAQ:MASS) - Defense World
908 Devices Inc. (MASS) Reports Q4 Loss, Tops Revenue Estimates - MSN
908 Devices Inc. SEC 10-K Report - TradingView
Repligen buying 908 Devices’ Bioprocess Analytics portfolio - BioWorld Online
908 Devices Makes Key Divestiture (Rating Upgrade) (NASDAQ:MASS) - Seeking Alpha
908 Devices earnings missed by $0.33, revenue fell short of estimates - Investing.com Australia
Stifel maintains Buy on 908 Devices, target steady at $6 By Investing.com - Investing.com Canada
Stifel maintains Buy on 908 Devices, target steady at $6 - Investing.com India
908 Devices Inc. Reports Strategic Transformation and Growth - MSN
Repligen lays down $70m to buy analytics tech from 908 Devices - BioProcess Insider
Repligen Purchases Bioprocessing Analytics Portfolio from 908 Devices - Genetic Engineering & Biotechnology News
908 Devices Inc.'s (NASDAQ:MASS) 55% Jump Shows Its Popularity With Investors - Simply Wall St
908 Devices Inc (MASS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
908 Devices stock surges on strategic transformation and growth outlook By Investing.com - Investing.com South Africa
908 Devices stock surges on strategic transformation and growth outlook - Investing.com
908 Devices Inc Stock (MASS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):